Angela Hong on Muck Rack

Angela Hong

Atlanta
As seen in: The Lancet, WSOC-TV (Charlotte, NC), KOKI-TV (Tulsa, OK), Journal-News, WPXI-TV (Pittsburgh, PA), The Cureus Journal of Medical Science, Journal of Nuclear Medicine, European Journal of Cancer, Nomuraconnects, EJSO - European Journal of Surgical Oncology
Former TV news reporter turned PR pro in #ATL! @EmoryUniversity grad. Go @Braves!
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Angela

Contact Angela, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Global Physical AI: Industrial Scaling Begins

|
By Angela Hong, Frank S Fan
| Nomuraconnects
As the Physical AI industry transitions from prototype to industrial rollout, we expect consolidation around platforms that secure system level integration, manufacturing discipline, and deployment ecosystems. We believe players with internal factories and balance-sheet capacity are structurally better positioned to navigate the transition.
Open in Who Shared Issue with article?

Global Autos Outlook: Hunting for Opportunities in Uncertain Times

|
By Anindya Das, Angela Hong, kapil singh, Siddhartha Bera, Joel Ying
| Nomuraconnects
Global auto sales volume growth outpaced estimates in 4Q24-1Q25; such outperformance was almost entirely led by China, where momentum will likely continue In the US, early-year sales surged as buyers rushed to beat tariff-driven price hikes, but ongoing trade barriers and higher costs pose significant headwinds for automakers Indonesia and Thailand face declines due to strict lending and weak demand, while India stands out with an improved outlook The US auto industry and related supply...
Open in Who Shared Issue with article?

Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study

|
By Siddhartha Baxi, Saima Vohra, Angela Hong, Nicola Mulholland
| Journal of Nuclear Medicine Verified
MATERIALS AND METHODS The EPIC-Skin trial (NCT05135052) is a prospective, multicenter, single-arm, open-label, phase IV study conducted at 7 sites worldwide: Australia (3 sites), South Africa (1 site), and Europe (Germany, Austria, and U.K., 1 site each). The objective is to assess clinic- and patient-reported outcomes of Rhenium SCT as a treatment for BCC and SCC. All patients will remain in the study for 24 mo from the time of their treatment with Rhenium SCT.
Open in Who Shared Issue with article?
See all 70 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified